The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. [electronic resource]
Producer: 20040802Description: 2984-90 p. digitalISSN:- 0953-816X
- Analysis of Variance
- Animals
- Behavior, Animal
- Cell Count
- Cell Division -- physiology
- Cells, Cultured
- Dextrans
- Ectodysplasins
- Encephalomyelitis, Autoimmune, Experimental -- immunology
- Female
- Immunohistochemistry -- methods
- Immunotherapy, Active -- methods
- Laminectomy -- methods
- Membrane Proteins -- metabolism
- Methylprednisolone -- therapeutic use
- Motor Activity -- physiology
- Mycobacterium -- immunology
- Myelin Basic Protein -- immunology
- Neuroprotective Agents -- therapeutic use
- Peptide Fragments -- immunology
- Rats
- Rats, Inbred Lew
- Rats, Sprague-Dawley
- Rhodamines
- Species Specificity
- Spinal Cord Injuries -- immunology
- T-Lymphocytes -- drug effects
- Time Factors
- Tryptophan -- analogs & derivatives
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.